Lung cancers
Targeted therapy favoured for asymptomatic brain metastases in oncogene-driven NSCLC
Higher radon exposure linked to increased lung cancer risk in UK-first study
Are lung cancer pathways keeping up with precision medicine?
Serial imaging-based deep learning effectively predicts survival in immunotherapy-treated NSCLC
Addressing persistent chemotherapy-induced alopecia: consensus recommendations
Registry data support safety of stereotactic radiotherapy with newer cancer treatments
Robotic-assisted bronchoscopy diagnostic yield three times higher than conventional techniques
Expediting genomic testing pathways: analysis of the UKLCC lung cancer report
Scheduled appointments superior to open invitations for lung cancer screening attendance
More effective immunotherapies possible as aspirin’s anti-metastatic mechanism discovered
Lung cancer pathway insights from Dr Zaheer Mangera part 2: neoadjuvant therapy
Preoperative ctDNA test shows promise in predicting early-stage lung adenocarcinoma outcomes
Lung cancer pathway insights from Dr Zaheer Mangera part 1: early diagnosis and screening
Perioperative pembrolizumab and overall survival in early-stage NSCLC
Dr John Conibear on the evolution of durvalumab in NSCLC care